All In Biotech

Free tool

FAERS Monitor: Allegra Hives

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020872 or its brand name (Allegra Hives, Fexofenadine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

21,085

Serious

6,968

33% of reports

Hospitalization

2,858

Death reported

575

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • drug ineffective3,718
  • headache953
  • fatigue928
  • pruritus921
  • nausea816
  • no adverse event780
  • diarrhoea738
  • dizziness707
  • extra dose administered701
  • rash678
  • dyspnoea665
  • somnolence611
  • cough608
  • insomnia548
  • pain546

Reports by year received

View as table
YearReports
2004148
2005140
200629
200731
200837
200948
201020
201137
2012118
2013159
2014170
2015358
20161,977
20172,191
20182,693
20191,215
20201,203
20211,220
20221,457
20232,021
20241,938
20252,049
20261,826

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,033,074 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
extra dose administeredSignal70117.516.310,755
no adverse eventSignal7804.34.01,987
somnolenceSignal6113.02.8836
drug ineffectiveSignal3,7182.82.74,642
pruritusSignal9212.42.2758
coughSignal6082.22.0384
insomniaSignal5482.11.9299
rash6781.61.4135
headache9531.51.4172
dizziness7071.41.387
fatigue9281.21.129
dyspnoea6651.21.117
diarrhoea7381.11.113
nausea8161.01.01
pain5460.90.88

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.